• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病中的表面抗原表达:聚类分析、相互关系及染色体异常的影响

Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.

作者信息

Hulkkonen J, Vilpo L, Hurme M, Vilpo J

机构信息

Department of Microbiology and Immunology, University of Tampere Medical School and Laboratory Center of Tampere University Hospital, Tampere, Finland.

出版信息

Leukemia. 2002 Feb;16(2):178-85. doi: 10.1038/sj.leu.2402363.

DOI:10.1038/sj.leu.2402363
PMID:11840283
Abstract

Chronic lymphocytic leukemia (CLL) is a phenotypically distinguishable form of B-lymphoid leukemias. The regularity of surface membrane antigen expression patterns, their interrelationships as well as the effects of the three frequent chromosomal aberrations, ie 11q deletion, 13q deletion and trisomy 12, were investigated in 35 classic CLL cases by flow cytometry. The two-way cluster analysis of 31 individual antigens revealed three expression patterns: (1) most cells in most cases positive (CD5, CD19, CD20, CD23, CD27, CD40, CD45, CD45RA); (2) most cells in most cases negative (CD10, CD14, CD34, CD122, CD154, mIgG); and (3) a mixed pattern with a variable number of positive cases and a variable percentage of positive cells in individual cases (CD11c, CD21, CD22, CD25, CD38, CD45RO, CD79b, CD80, CD95, CD124, CD126, CD130, FMC7, mIgD, mIgkappa, mIglambda, mIgM). The expressions of several antigens were strongly interdependent, even when antigens belonged to entirely different gene families. Such antigen pairs were: CD11c/CD21; CD19/CD45; CD19/CD79b; CD22/CD45RA; CD23/Igkappa; CD25/mIgM; CD27/CD45; CD45/CD79b; CD45RA/Igkappa. In contrast, the expression of some antigens was mutually exclusive, the best examples being CD45RA/CD45RO, CD38/CD80 and CD45RA/CD80. Deletion of chromosome arm 11q attenuated expression of splicing variant CD45RA, but enhanced CD45RO expression. In contrast, cases of trisomy 12 were associated with enhanced CD45RA and attenuated CD45RO expression. Similarly, trisomy 12 was associated with enhanced CD27 and mIgkappa expression. The variable levels of signaling surface membrane antigens, their interactions and interference by genetic aberrations are likely to affect the clinical progression and drug response of CLL.

摘要

慢性淋巴细胞白血病(CLL)是B淋巴细胞白血病的一种表型可区分的形式。通过流式细胞术对35例经典CLL病例的表面膜抗原表达模式的规律性、它们之间的相互关系以及三种常见染色体畸变(即11q缺失、13q缺失和三体12)的影响进行了研究。对31种个体抗原的双向聚类分析揭示了三种表达模式:(1)大多数病例中的大多数细胞呈阳性(CD5、CD19、CD20、CD23、CD27、CD40、CD45、CD45RA);(2)大多数病例中的大多数细胞呈阴性(CD10、CD14、CD34、CD122、CD154、mIgG);(3)一种混合模式,个别病例中阳性病例数量和阳性细胞百分比各不相同(CD11c、CD21、CD22、CD25、CD38、CD45RO、CD79b、CD80、CD95、CD124、CD126、CD130、FMC7、mIgD、mIgκ、mIgλ、mIgM)。即使抗原属于完全不同的基因家族,几种抗原的表达也高度相互依赖。这样的抗原对有:CD11c/CD21;CD19/CD45;CD19/CD79b;CD22/CD45RA;CD23/Igκ;CD25/mIgM;CD27/CD45;CD45/CD79b;CD45RA/Igκ。相反,一些抗原的表达相互排斥,最好的例子是CD45RA/CD45RO、CD38/CD80和CD45RA/CD80。染色体臂11q的缺失减弱了剪接变体CD45RA的表达,但增强了CD45RO的表达。相反,三体12的病例与CD45RA表达增强和CD45RO表达减弱有关。同样,三体12与CD27和mIgκ表达增强有关。信号表面膜抗原的可变水平、它们的相互作用以及基因畸变的干扰可能会影响CLL的临床进展和药物反应。

相似文献

1
Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.慢性淋巴细胞白血病中的表面抗原表达:聚类分析、相互关系及染色体异常的影响
Leukemia. 2002 Feb;16(2):178-85. doi: 10.1038/sj.leu.2402363.
2
Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells.外源性生长因子体外诱导慢性淋巴细胞白血病细胞表面膜抗原表达的变化
Leukemia. 2002 Sep;16(9):1691-8. doi: 10.1038/sj.leu.2402583.
3
Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.12号染色体三体、13号染色体长臂缺失、17号染色体短臂缺失及11号染色体长臂缺失对慢性淋巴细胞白血病中白血病B细胞免疫表型、DNA倍体状态及增殖率的影响
Cytometry B Clin Cytom. 2008 May;74(3):139-49. doi: 10.1002/cyto.b.20390.
4
Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.对取自不同解剖部位的样本中,非霍奇金B细胞淋巴瘤抗原表达模式进行流式细胞术免疫表型分析。
Ann N Y Acad Sci. 2004 Dec;1028:457-62. doi: 10.1196/annals.1322.054.
5
Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.丝裂原诱导的未突变和超突变慢性淋巴细胞白血病细胞的活化、增殖及表面抗原表达模式
Eur J Haematol. 2005 Jul;75(1):34-40. doi: 10.1111/j.1600-0609.2005.00443.x.
6
Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的表面抗原表达及其与可变重链基因突变状态的相关性
Eur J Haematol. 2003 Jan;70(1):53-9. doi: 10.1034/j.1600-0609.2003.02838.x.
7
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的V(H)突变状态、CD38表达水平、基因组畸变与生存情况
Blood. 2002 Aug 15;100(4):1410-6.
8
Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.使用分化群抗体微阵列对白血病进行免疫表型分析。
Cancer Res. 2001 Jun 1;61(11):4483-9.
9
Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.467例B细胞慢性淋巴细胞增殖性疾病患者的表型异常发生率:用于微小残留病研究的特定四色染色设计基础
Leukemia. 2002 Aug;16(8):1460-9. doi: 10.1038/sj.leu.2402584.
10
Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.伴有11号染色体缺失和12号染色体三体异常的慢性淋巴细胞白血病患者侵袭性疾病的分子基础。
Int J Mol Med. 2007 Oct;20(4):461-9.

引用本文的文献

1
VISTA is a potential target for immunotherapy in B-cell acute lymphoblastic leukemia in children.VISTA是儿童B细胞急性淋巴细胞白血病免疫治疗的一个潜在靶点。
Sci Rep. 2025 Jul 3;15(1):23809. doi: 10.1038/s41598-025-08164-2.
2
Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia.嵌合抗原受体 T 细胞疗法在慢性淋巴细胞白血病中的现状。
Int J Mol Sci. 2021 May 24;22(11):5536. doi: 10.3390/ijms22115536.
3
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.
抗原表达强度反映了慢性淋巴细胞白血病、单克隆 B 细胞淋巴增生症和小淋巴细胞淋巴瘤中的 IGHV 突变状态和多纳定义的预后类别。
Leuk Lymphoma. 2021 Aug;62(8):1828-1839. doi: 10.1080/10428194.2021.1894641. Epub 2021 Mar 18.
4
Quercetin shortened survival of radio-resistant B-1 cells and by restoring miR15a/16 expression.槲皮素通过恢复miR15a/16的表达缩短了抗辐射B-1细胞的生存期。
Oncotarget. 2021 Feb 16;12(4):355-365. doi: 10.18632/oncotarget.27883.
5
Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia.非编码RNA在慢性淋巴细胞白血病靶向治疗和免疫治疗方法发展中的作用
J Clin Med. 2020 Feb 21;9(2):593. doi: 10.3390/jcm9020593.
6
Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.慢性淋巴细胞白血病中固有免疫细胞和适应性免疫细胞的分子相互作用及其治疗意义。
Front Immunol. 2018 Nov 26;9:2720. doi: 10.3389/fimmu.2018.02720. eCollection 2018.
7
Analysis of ROR1 Protein Expression in Mice with Reconstituted Human Immune System Components.分析在重建的人免疫系统成分的老鼠中的 ROR1 蛋白质表达。
J Immunol Res. 2018 Apr 18;2018:2480931. doi: 10.1155/2018/2480931. eCollection 2018.
8
Automated Analysis of Clinical Flow Cytometry Data: A Chronic Lymphocytic Leukemia Illustration.临床流式细胞术数据的自动化分析:以慢性淋巴细胞白血病为例
Clin Lab Med. 2017 Dec;37(4):931-944. doi: 10.1016/j.cll.2017.07.011.
9
Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.表型与基因型相结合可改善急性髓细胞白血病的预后预测:来自儿童肿瘤学组协议 AAML0531 的报告。
Haematologica. 2017 Dec;102(12):2058-2068. doi: 10.3324/haematol.2017.169029. Epub 2017 Sep 7.
10
Tumorigenesis promotes Mdm4-S overexpression.肿瘤发生促进Mdm4-S的过表达。
Oncotarget. 2017 Apr 18;8(16):25837-25847. doi: 10.18632/oncotarget.15552.